Company profile: Genomic Health
1.1 - Company Overview
Company description
- Provider of genomic-based diagnostic tests addressing overtreatment and optimal treatment of early-stage cancer. Offers Oncotype DX Breast Recurrence Score for ER+/HER2- breast cancer, Riskguard Hereditary Cancer Test, OncoExTra genomic profiling for advanced/metastatic cancer, and developing colorectal screening (Next Generation Cologuard, blood test) and a Breast Radiation Score.
Products and services
- Oncotype DX Breast Recurrence Score: A genomic-based test that helps assess breast cancer recurrence risk and informs treatment decisions for patients with early-stage ER+/HER2- breast cancer
- OncoExTra Genomic Profiling Test: A comprehensive test that helps identify targeted therapy options for patients with advanced or metastatic cancer through genomic profiling, informing precision treatment choices
- Riskguard Hereditary Cancer Test: A hereditary-focused test that identifies hereditary genetic changes associated with increased cancer risk, aiding personalized prevention and treatment strategies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genomic Health
OpGen
HQ: United States
Website
- Description: Provider of precision medicine solutions utilizing molecular diagnostics and bioinformatics to help combat infectious disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OpGen company profile →
Instant Labs
HQ: United States
Website
- Description: Provider of a fully-integrated, portable, and affordable real-time polymerase chain reaction (RT-PCR) platform for rapid, accurate pathogen detection, developing and marketing the Hunter Real-Time-PCR system. Focus areas include molecular diagnostic equipment, food safety testing equipment, and food verification testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Instant Labs company profile →
AutoGenomics
HQ: United States
Website
- Description: Provider of automated microarray-based multiplex molecular diagnostic platforms and genetic testing tools, including INFINITI System, INFINITI PLUS Analyzer, INFINITI High Throughput System, proprietary BioFilmChip microarrays, and assays such as AvertD for opioid use disorder risk and Factor II-V Leiden for thrombophilia, for disease signature assessment in women's health, cancer and personalized medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AutoGenomics company profile →
Lysogene
HQ: France
Website
- Description: Provider of basic research and clinical development of gene therapy for neurodegenerative disorders, developing AAV vectors, with a mission to improve the health of patients with incurable, life-threatening conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lysogene company profile →
Basepaws
HQ: United States
Website
- Description: Provider of at-home genetic testing for cats and dogs, including cat and dog DNA tests for breed analysis, trait information, and health risk markers; cat oral microbiome tests to screen for dental diseases; and whole genome sequencing for cats providing extensive genome data on health, traits, and breed.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Basepaws company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genomic Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genomic Health
2.2 - Growth funds investing in similar companies to Genomic Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genomic Health
4.2 - Public trading comparable groups for Genomic Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →